Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.00 (+2.09%)
At close: Aug 21, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Debt Ratio (2022 - 2026)

Theriva Biologics (TOVX) posted quarterly Debt Ratio of 0.07 for Q1 2026, up 52.44% year-over-year from 0.05 in Q1 2025, and up 63.1% quarter-over-quarter from 0.05 in Q4 2025.

Theriva Biologics (TOVX) Debt Ratio (2022 - 2026) Analysis & Trends

Theriva Biologics (TOVX) has reported Debt Ratio for 5 consecutive years, with 0.07 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio rose 52.44% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (up 52.44% YoY), while the FY2025 annual figure was 0.05, up 944.14% from the prior year.
  • Debt Ratio rose to 0.07 in Q1 2026 per TOVX's latest filing, from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.11 in Q3 2022 and bottomed at 0.0 in Q1 2023.
  • Historically, Debt Ratio has averaged 0.04 across 5 years, with a median of 0.0 in 2024.
  • Annual changes were most pronounced in 2023 — Debt Ratio tumbled 96.94% — and 2025, when it soared 1265.32%.
  • Theriva Biologics' Debt Ratio stood at 0.0 in 2022, then climbed by 5.33% to 0.0 in 2023, then advanced by 6.21% to 0.0 in 2024, then jumped by 944.14% to 0.05 in 2025, then soared by 63.1% to 0.07 in 2026.
  • Business Quant data shows TOVX's Debt Ratio at 0.07 in Q1 2026, 0.05 in Q4 2025, and 0.06 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 Theriva Biologics 10.64 Mn 10.64 Mn - 0.12

Historic Data

Download Data
DateValue
Jun 30, 2026 0.12
Mar 31, 2026 0.07
Dec 31, 2025 0.05
Sep 30, 2025 0.06
Jun 30, 2025 0.05
Mar 31, 2025 0.05
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.08
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.11
Jun 30, 2022 0.11
Mar 31, 2022 0.00